SB 432 expands probation eligibility for certain major controlled substances offenses (excluding heroin, fentanyl, carfentanil, and their derivatives) that were previously ineligible under Michigan law. It allows courts to delay sentencing for up to one year to enable defendants to participate in drug treatment programs, requiring the court to document the reason for the delay in writing. The bill establishes a monthly supervision fee of $30 (without electronic monitoring) or $60 (with monitoring), capped at 12 months, which can be paid in installments or waived for indigent individuals. This applies to adult defendants not subject to juvenile probation.
HB 5259 establishes a peer mentorship program within Michigan's Department of Military and Veterans Affairs to connect active-duty military members (including National Guard and reserves) and veterans with volunteer mentors. The program helps participants access resources for education, employment, family issues, financial matters, and health care - including mental health and substance use disorder support through veteran navigators. Mentors must be recruited from veterans where possible, and program records are protected from public disclosure under Michigan's freedom of information law. The bill requires companion legislation (HB 5270) to take effect.
HB 4417 requires Michigan's state department to provide opioid antagonists (like naloxone) at no cost to life support agencies - such as ambulance services - when requested. This directly affects emergency medical services (EMS) providers operating life support vehicles, ensuring these vehicles are equipped to respond to opioid overdoses. The bill amends Michigan's Public Health Code to mandate this free distribution, streamlining access for first responders. It focuses on concrete policy change: making overdose-reversal medications readily available in emergency vehicles without cost to EMS agencies.
HB 4428 allows individuals and governmental entities receiving free opioid overdose reversal medications (opioid antagonists) from the Department of Health and Human Services (DHHS) to choose the specific type, dose, or delivery method of the medication. This provision applies when the DHHS distributes these medications to help reduce opioid-related overdoses across the state. The choice is intended to help recipients better address local needs. However, recipients cannot choose a specific formulation or dosage if doing so would jeopardize federal funding for the DHHS.
HB 4684 requires Michigan health insurers to create and submit a plan ensuring coverage for a broad range of pain management services, including nonopioid medications and nonmedication alternatives to opioids. The plan must be filed with the state insurance department for approval, which will review whether the plan adequately covers alternatives to opioids without unduly favoring opioid prescriptions. Insurers must also distribute educational materials to network providers and post the plan on their public website. This bill directly affects all health insurers operating in Michigan who issue, deliver, or renew health insurance policies in the state.
SB 222 expands who can petition for continued involuntary mental health treatment under Michigan's assisted outpatient program. It adds psychiatric nurse practitioners and physician assistants (working under a psychiatrist's delegation) to the list of eligible petitioners and allows individuals aged 18 or older to file petitions for themselves. Petitions must include a clinical certificate and evidence of a psychiatrist's consultation (unless the filer is a psychiatrist), along with details about the treatment program and estimated duration needed. This change directly affects patients requiring ongoing treatment and increases the number of authorized mental health providers who can initiate the petition process.
SB 404 requires public schools in Michigan to ensure at least one staff member at each school is trained to administer naloxone (an opioid overdose reversal medication) if the state health department provides it at no cost. Schools must develop policies requiring staff to notify parents when naloxone is used and call 9-1-1 for suspected opioid overdoses. The bill directly affects public school districts, intermediate districts, and public school academies by mandating training and response protocols for opioid-related emergencies. It specifies naloxone must be FDA-approved and defines "opioid-related overdose" to include symptoms like respiratory depression or unconsciousness needing medical help.
SB 629 creates a legal framework for needle and syringe access programs in Michigan to reduce the spread of communicable diseases like HIV and hepatitis. It allows authorized programs (run by health departments or local agencies) to distribute sterile needles/syringes and provide related services. Participants in these programs are exempt from criminal penalties under existing laws for possessing needles, trace amounts of drugs in used equipment, or drug testing supplies. The bill directly affects people who use injection drugs, local health programs, and law enforcement by clarifying that program participation does not violate drug possession or paraphernalia laws.
HB 4095 requires Michigan health insurers to process mental health and substance use disorder provider credentialing applications within 60 calendar days (or up to 75 days with justification). Insurers must send written requests for missing information within 10 business days and reimburse providers for covered services if they miss deadlines, using standard in-network rates. This directly affects mental health professionals (like psychologists, licensed social workers, and counselors) seeking to join insurer networks and the insurers themselves. The bill applies to both initial applications and recredentialing, aiming to reduce delays in provider network access.
SB 142 amends Michigan's Mental Health Code (MCL 330.1100d and 330.1756) to modify the membership and advisory role of the State Recipient Rights Advisory Committee. Specifically, it clarifies that this committee advises both the director of the department and the director of the department's State Office of Recipient Rights, as established under Section 756. The bill updates definitions related to mental health services, substance use disorder treatment, and specialized residential care but does not create new programs or funding. This is a procedural amendment focused on clarifying committee structure and responsibilities.
